These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37933414)

  • 1. Stakeholders' Perceptions Regarding Digital Therapeutics Reimbursement in South Korea: Qualitative Study.
    Sim B; Ju JH; Kim B; Lee JY
    JMIR Mhealth Uhealth; 2023 Oct; 11():e47407. PubMed ID: 37933414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Success Factors for Scaling Up the Adoption of Digital Therapeutics Towards the Realization of P5 Medicine.
    Prodan A; Deimel L; Ahlqvist J; Birov S; Thiel R; Toivanen M; Kolitsi Z; Kalra D
    Front Med (Lausanne); 2022; 9():854665. PubMed ID: 35492346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The views of public service managers on the implementation of National Health Insurance in primary care: a case of Johannesburg Health District, Gauteng Province, Republic of South Africa.
    Murphy SD; Moosa S
    BMC Health Serv Res; 2021 Sep; 21(1):969. PubMed ID: 34521399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Access and reimbursement pathways for digital health solutions and
    Mantovani A; Leopaldi C; Nighswander CM; Di Bidino R
    Front Med Technol; 2023; 5():1101476. PubMed ID: 36891483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public awareness and knowledge of the National Health Insurance in South Africa.
    Setswe G; Muyanga S; Witthuhn J; Nyasulu P
    Pan Afr Med J; 2015; 22():19. PubMed ID: 26600918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reimbursement of Digital Therapeutics: Future Perspectives in Korea.
    Ju JH; Sim B; Lee J; Lee JY
    Korean Circ J; 2022 Apr; 52(4):265-279. PubMed ID: 35388995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical device reimbursement coverage and pricing rules in Korea: current practice and issues with access to innovation.
    Lee SS; Salole E
    Value Health; 2014 Jun; 17(4):476-81. PubMed ID: 24969010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Will private health insurance schemes subscriptions continue after the introduction of National Health Insurance in Uganda?
    Zikusooka CM; Kyomuhang RL; Orem JN; Tumwine M
    Afr Health Sci; 2009 Oct; 9 Suppl 2(Suppl 2):S66-71. PubMed ID: 20589109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eight-year experience of using HTA in drug reimbursement: South Korea.
    Bae EY; Hong JM; Kwon HY; Jang S; Lee HJ; Bae S; Yang BM
    Health Policy; 2016 Jun; 120(6):612-20. PubMed ID: 27086557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing the preparedness for the implementation of the national health insurance scheme at a selected hospital in Gauteng Province, South Africa.
    Mukwena NV; Manyisa ZM
    BMC Health Serv Res; 2022 Aug; 22(1):1006. PubMed ID: 35933346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Historical account of the national health insurance formulation in Kenya: experiences from the past decade.
    Abuya T; Maina T; Chuma J
    BMC Health Serv Res; 2015 Feb; 15():56. PubMed ID: 25884159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health financing policy formulation in the Eastern Caribbean.
    Huff-Rousselle M; Lalta S; Fiedler JL
    Int J Health Plann Manage; 1998; 13(2):149-63. PubMed ID: 10185506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights into insurance coverage for digital therapeutics: A qualitative study of US payer perspectives.
    Lumbreras AG; Hurwitz JT; Liang X; Schippers S; Phillip K; Bhattacharjee S; Waters HC; Malone DC
    J Manag Care Spec Pharm; 2024 Apr; 30(4):313-325. PubMed ID: 38555623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptability to general practitioners of national health insurance and capitation as a reimbursement mechanism.
    Blecher MS; Bachmann MO; McIntyre D
    S Afr Med J; 1995 Sep; 85(9):847-51. PubMed ID: 8545741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A qualitative interview study of patients' attitudes towards and intention to use digital interventions for depressive disorders on prescription.
    Posselt J; Baumann E; Dierks ML
    Front Digit Health; 2024; 6():1275569. PubMed ID: 38375490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public engagement in the development of the National Health Insurance: a study involving patients from a central hospital in South Africa.
    Tandwa LA; Dhai A
    BMC Public Health; 2020 Jul; 20(1):1191. PubMed ID: 32736616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferences on policy options for ensuring the financial sustainability of health care services in the future: results of a stakeholder survey.
    Tordrup D; Angelis A; Kanavos P
    Appl Health Econ Health Policy; 2013 Dec; 11(6):639-52. PubMed ID: 24129648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Private health insurance in South Korea: an international comparison.
    Shin J
    Health Policy; 2012 Nov; 108(1):76-85. PubMed ID: 22958939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMCP Partnership Forum: Digital Therapeutics-What Are They and Where Do They Fit in Pharmacy and Medical Benefits?
    J Manag Care Spec Pharm; 2020 May; 26(5):674-681. PubMed ID: 32175784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMCP Partnership Forum: The evolving role of digital therapeutics.
    J Manag Care Spec Pharm; 2022 Jul; 28(7):804-810. PubMed ID: 35699389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.